期刊文献+

Rac1 VEGF在肝细胞癌中的表达和肿瘤血管形成关系 被引量:11

Rac1 and VEGF expressions in hepatocellular carcinoma and its relationship with tumor angiogenesis
下载PDF
导出
摘要 目的:探讨Rac1、VEGF蛋白在肝细胞癌组织的表达及其与肿瘤血管形成的关系。方法:应用免疫组织化学法检测Rac1、VEGF在43例肝细胞癌组织、43例癌旁肝组织及21例正常肝组织的表达,采用图像分析软件测定Rac1蛋白、VEGF蛋白的平均光密度,根据CD34染色的血管内皮细胞计数肿瘤MVD。结果:Rac1蛋白在癌组织、癌旁肝组织及正常肝组织均有表达,位于胞浆,癌组织表达高于癌旁肝组织(P<0.01)、正常肝组织(P<0.01);VEGF蛋白在癌组织、癌旁肝组织及正常肝组织均有表达,位于胞浆,癌组织高于癌旁肝组织(P<0.01)、正常肝组织(P<0.01);Rac1、VEGF与MVD之间均呈正相关(r=0.490,P=0.001;r=0.355,P=0.019),Rac1与VEGF之间呈正相关(r=0.583,P<0.001)。结论:Rac1可能通过上调VEGF的表达促进肿瘤血管生成,参与HCC的侵袭、转移机制。 Objective: This study aimed to detect Racl and vascular endothelial growth tactor (VEGF) expressions m nepatoceHuiar carcinoma (HCC) and to correlate this expression with tumor angiogenesis. Methods: Racl and VEGF expressions in 43 specimens of HCC, 43 specimens of adjacent nontumorous liver tissue, and 21 specimens of normal liver tissues were detected by immunohistochemistry. Image analysis software was used to conduct a quantitative analysis of Racl and VEGF expressions by accessing their mean optical density (MOD). Microvascular density (MVD) was determined by labeling the vascular endothelial cells with CD34. Results: Racl protein expression occurred mainly in the HCC tissue of the cytoplasm. MOD in HCC tissue was markedly higher than those in adjacent nontumorous liver tissue (P〈0.01) and in normal liver tissue (P〈0.01). The expression of VEGF protein was higher in HCC tissue than those in adjacent non-tumorous liver tissue (P〈0.01) and normal liver tissue (P〈0.01). Moreover, the Racl and VEGF protein expressions in HCC were positively correlated with MVD (r-0.490, P-0.001; r=0.355, P=0.019). Racl protein expression in HCC tissue was positively correlated with the VEGF protein expression in HCC tissue (r-0.583, P-0.000). Conclusion: Racl possibly promotes tumor angiogenesis through the upregulation of VEGF expression, and is associated with HCC invasion and metastasis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第4期212-216,共5页 Chinese Journal of Clinical Oncology
基金 福建省卫生厅青年科研课题(编号:2007-02-18) 福建省泉州市技术研究与开发项目计划重点项目(编号:2009Z18)资助~~
关键词 肝细胞癌 RAC1 VEGF 微血管密度 免疫组织化学 hepatocellular carcinoma, Rac 1, VEGF, MVD, immunohistochemistry
  • 相关文献

参考文献11

  • 1Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis ofhepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2004, 130(4):187-196.
  • 2Weidner N.Current pathologic methods for measuring intratumor-al micro vessel density within breast carcinoma and other solid tu-mors [J]. Breast Cancer Res Treat, 1995, 36(2):169-180.
  • 3Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motilitycontrol[J]. Cell Commun Signal, 2010,8:23.
  • 4苏龙,续薇,闫光志,罗薇,王英丽,陈爽,张阳,刘立华.Ras相关的C3肉毒素底物1蛋白在胃癌组织中的表达和分布以及与胃癌进展的关系[J].中华肿瘤杂志,2011,33(9):676-680. 被引量:4
  • 5Heid I, Lubeseder—Martellato C, Sipos B, et al. Early requirementof Racl in a mouse model of pancreatic cancer[J]. Gastroenterology,2011,141(2):719-730.
  • 6Gastonguay A, Berg T, Hauser AD, et al. The role of Racl in theregulation of NF—kB activity, cell proliferation, and cell migrationin non—small cell lung carcinoma[J]. Cancer Biol Ther, 2012,13(8):647-656.
  • 7Sahai E, Marshall CJ. Rho—GTPases and cancer [J]. Nat Rev Can-cer, 2002,2(2):133-142.
  • 8Velaithan R, KangJ, HirparaJL, et al. The small GTPase Racl is anovel binding partner of Bel—2 and stabilizes its antiapoptotic activi-ty^. Blood, 2011, 117(23):6214-6226.
  • 9吴力群,卢云,卢华军,张斌,杨金镛,马湘.细胞因子E-cadherin、CD34在肝细胞肝癌患者预后评价中的价值[J].中华外科杂志,2006,44(11):774-777. 被引量:6
  • 10Zhang L, Wang JN, Tang JM, et al. VEGF is essential for thegrowth and migration of human hepatocellular carcinoma cells [J].Mol Biol Rep,2012,39(5):5085-5093.

二级参考文献20

  • 1Garrett TA, Van Buttl JD, Burridge K. VEGF-induced Racl activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp Cell Res, 2007, 313:3285-3297.
  • 2Walch A, Seidl S, Hermannstadter C, et al. Combined analysis of Racl, IQGAP1, Tiaml and E-cadherin expression in gastric cancer. Mod Pathol, 2008, 21:544-552.
  • 3Krotz F, Keller M, Derflinger S, et al. Mycophenolate acid inhibits endothelial NAD(P) H oxidase activity and superoxide formation by a Racl-dependent mechanism. Hypertension, 2007,49:201-208.
  • 4Whaley-C-nnell AT, Morris EM, Refer N, et al. Albumin activation of NAD(P) H oxidase activity is mediated via Racl in proximal tubule cells. Am J Nephrol, 2007, 27:15-23.
  • 5Wennerberg K, Der CJ. Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci, 2004, 117:1301-1312.
  • 6Pan Y, Bi F, Liu N, et al. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commnn, 2004, 315:686-691.
  • 7Ichikura T, Tomimatsu S, Uefuji K, et al. Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer, 1999, 86:553-558.
  • 8Polyak K, Weinberg RA. Transitions between epithelial arid mesenchymal states: acquisition of malignant and stern cell traits. Nat Rev Cancer, 2009, 9:265-273.
  • 9Espina C, C6spedes MV, Garcia-Cabezas MA, et al. A critical role for Racl in tumor progression of human colorectal adenocarcinoma cells. Am J Pathol, 2008, 172:156-166.
  • 10Michaelson D, Abidi W, Guardavaccam D, et al. Racl accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol, 2008, 181:485-496.

共引文献23

同被引文献95

  • 1郝晓凤,惠延年,王雨生,张鹏,徐建锋,刘晓娟,赵炜.Rac1和HIF-1在激光诱导小鼠脉络膜新生血管模型组织中的表达[J].眼科新进展,2007,27(6):401-404. 被引量:3
  • 2Jemal A, Murray T,Samuels A,et al. Cancer statistics 2003 [J]. CA Cancer J Clin ,2003,53:5-26.
  • 3Belani CP,Goss G,Blumenschein G. Recent clinical develop- menls and rationale for combining targeted agents in non- small cell lung caneer(NSCLC) [J]. Cancer Treatment Reviews, 2012,38(3): 173-184.
  • 4Le T, Dat T, Matsuo. Identification of genes potentially involved in bone lnetastasis by genome-wide gene expression profile anal- ysis of non-small cell lung cancer in mice [J]. International jour- nal of oncnlogy, 2012,40 (5) : 1455-1469.
  • 5Koichi ,Yoshiyama, Yasuhiro,et al. Personalized peptide vac- cination in patients with refractory non-small cell lung can- cer [J]. International Journal of Ontology ,2012,40(5 ):1492- 1500.
  • 6王官成.VEGF在肿瘤血管及淋巴管生成中的研究[J].中国普通外科进展,2013,16(3):240-243.
  • 7Shibuya M.Vascular Endothelial Growth Factor(VEGF) and Its Re- ceptor(VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti and Pro-Angiogenic Therapies[J].Genes Cancer, 2011,2 (12):1097-1105.
  • 8Meyer A, Uder M, Lang W, et al. Visceral artery aneurysms[J]. Zentralbl Chir, 2010,135(5):416-420.
  • 9Patruno R, Arpaia N, Gadalet CD, et al.VEGF concentration from plasma activated platelets rich correlates with microvascular densi- ty and grading in canine mast cell tumour spontaneous model[J]. Cell Mol Med,2009,13(3):555-561.
  • 10Pooh RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma:a pro- spective sudy[J]. Ann Surg,2001,233(2):227-235.

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部